[Study on the mechanism of preventing alcholic liver disease by selective cyclooxygenase 2 inhibitor].
Zhou
Jun-ying
JY
Infectious Department, Third Hospital, Hebei Medical University, Shijiazhuang 050051, China. doctorzhoujy@163.com
Zhou
Dong-fang
DF
Liu
Ying-hui
YH
Wang
Wei
W
Wei
Feng
F
D000818:Animals; D000068579:Celecoxib; D051545:Cyclooxygenase 1 / Q000235:genetics / Q000378:metabolism; D051546:Cyclooxygenase 2 / Q000235:genetics / Q000378:metabolism*; D052246:Cyclooxygenase 2 Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D016207:Cytokines / Q000378:metabolism; D004195:Disease Models, Animal; D000431:Ethanol / Q000009:adverse effects; D005235:Fatty Liver, Alcoholic / Q000473:pathology / Q000517:prevention & control; D007150:Immunohistochemistry; D008099:Liver / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D008104:Liver Cirrhosis, Alcoholic / Q000473:pathology / Q000517:prevention & control; D008108:Liver Diseases, Alcoholic / Q000473:pathology / Q000517:prevention & control*; D011720:Pyrazoles / Q000494:pharmacology* / Q000627:therapeutic use; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013449:Sulfonamides / Q000494:pharmacology* / Q000627:therapeutic use
D052246:Cyclooxygenase 2 Inhibitors; D016207:Cytokines; D011720:Pyrazoles; D012333:RNA, Messenger; D013449:Sulfonamides; D000431:Ethanol; D051545:Cyclooxygenase 1; D051546:Cyclooxygenase 2; D000068579:Celecoxib